VS-4718 is under investigation in clinical trial NCT02215629 (Dose Escalation Study in Acute Myeloid or B-Cell Acute Lymphoblastic Leukemia).
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.